These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 19415276)
21. Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells. Zhuang ZH; Tsao SW; Deng W; Wang JD; Xia HH; He H; Feng HC; Wang LD; Gu Q; Lam SK; Lin MC; Kung HF; Wong BC J Gastroenterol Hepatol; 2008 Oct; 23(10):1613-20. PubMed ID: 18717758 [TBL] [Abstract][Full Text] [Related]
22. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Pendino F; Flexor M; Delhommeau F; Buet D; Lanotte M; Segal-Bendirdjian E Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6662-7. PubMed ID: 11371621 [TBL] [Abstract][Full Text] [Related]
23. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer. Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678 [TBL] [Abstract][Full Text] [Related]
24. [Inhibition of anti-sense human telomerase reverse transcriptase (hTERT) retroviral vector on lung cancer cells]. Tian FJ; Wang ZY; Ma JY; Zhao YX; Lu W Ai Zheng; 2004 May; 23(5):545-9. PubMed ID: 15142451 [TBL] [Abstract][Full Text] [Related]
25. Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma. Li Y; Li M; Yao G; Geng N; Xie Y; Feng Y; Zhang P; Kong X; Xue J; Cheng S; Zhou J; Xiao L Cancer Gene Ther; 2011 May; 18(5):318-25. PubMed ID: 21233858 [TBL] [Abstract][Full Text] [Related]
26. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity. Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057 [TBL] [Abstract][Full Text] [Related]
27. Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner. Zhao P; Wang C; Fu Z; You Y; Cheng Y; Lu X; Lu A; Liu N; Pu P; Kang C; Salford LG; Fan X Int J Oncol; 2007 Aug; 31(2):361-8. PubMed ID: 17611693 [TBL] [Abstract][Full Text] [Related]
28. shRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity. Zou L; Zhang P; Luo C; Tu Z Cancer Chemother Pharmacol; 2006 Feb; 57(3):328-34. PubMed ID: 16028098 [TBL] [Abstract][Full Text] [Related]
29. Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis. Cheng YW; Wu TC; Chen CY; Chou MC; Ko JL; Lee H Clin Cancer Res; 2008 Nov; 14(22):7173-9. PubMed ID: 19010833 [TBL] [Abstract][Full Text] [Related]
30. [Construction of an expression vector carrying short hairpin RNA targeting hTERT gene and its effects on breast cancer cell telomerase activity and proliferation in vivo]. Liu XX; Yao C; Zhang H; Wang SM; Wang SM Nan Fang Yi Ke Da Xue Xue Bao; 2009 Nov; 29(11):2187-90. PubMed ID: 19923062 [TBL] [Abstract][Full Text] [Related]
31. [The construction of lentivirus-mediated RNAi vector containing hTERT]. Zhao P; Fu Z; You YP; Wang CZ; Cheng YX; Lu XM; Lu A; Liu N Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):27-31. PubMed ID: 18247299 [TBL] [Abstract][Full Text] [Related]
32. [Suppression of telomerase activity by plasmid-mediated RNA interference]. Li Y; Li M; Peng Y; Jiang Z; Li W; Li H Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):615-9. PubMed ID: 16856401 [TBL] [Abstract][Full Text] [Related]
33. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells. Goldkorn A; Blackburn EH Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715 [TBL] [Abstract][Full Text] [Related]
34. Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase. Nowak T; Januszkiewicz D; Zawada M; Pernak M; Lewandowski K; Rembowska J; Nowicka K; Mankowski P; Nowak J Oncol Rep; 2006 Aug; 16(2):301-5. PubMed ID: 16820907 [TBL] [Abstract][Full Text] [Related]
35. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer. Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of telomerase with human telomerase reverse transcriptase antisense increases the sensitivity of tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells. Gao XD; Chen YR Asian J Androl; 2007 Sep; 9(5):697-704. PubMed ID: 17712489 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of human telomerase reverse transcriptase in hep-2 cells using short hairpin RNA expression vectors. Chen SM; Tao ZZ; Hua QQ; Liu D; Chi HM; Cai Q Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):200-5. PubMed ID: 16490880 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of telomerase activity in cancer cells using short hairpin RNA expression vectors. Chen SM; Tao ZZ; Hua QQ; Xiao BK; Xu Y; Wang Y; Deng YQ Cancer Invest; 2007 Dec; 25(8):691-8. PubMed ID: 18058464 [TBL] [Abstract][Full Text] [Related]
39. [Construction of adenovirus expressing siRNA against hTR and its anti-tumor activity in vitro]. Li Y; Xiao LY; Yao G; Li H; Yang ZW; Li WY; Jiang ZH; Li MY Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):570-3. PubMed ID: 18538086 [TBL] [Abstract][Full Text] [Related]
40. Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo. Kunze D; Wuttig D; Kausch I; Blietz C; Blumhoff L; Burmeister Y; Kraemer K; Fuessel S; Toma M; Schwenzer B; Meye A; Grimm MO; Hakenberg OW; Jocham D; Wirth MP Int J Oncol; 2008 May; 32(5):1049-56. PubMed ID: 18425331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]